LINC00632 and prostate carcinoma: In the sequencing results, the expression of CDR1as in PC3 was nearly 200 times higher than that in normal prostate epithelial cells and prostate carcinoma epithelial cells, suggesting that CDR1as may substantially contribute to bone metastatic progress of PCa.